Jointech-Med

Company Overview

Snapshot

Founded in May 2008 by Natanja Slager and Nir Altschuler, Jointech-Med operates with 1–10 employees. The company is currently in a non-active status as of February 2010.

Business overview

Jointech-Med is focused on developing an intra-articular device designed to reduce intra-articular pressure and continuously evacuate inflammatory mediators from painful, effused knees. This technology aims to alleviate pain, improve quality of life, and decelerate disease progression in patients suffering from conditions like osteoarthritis and rheumatoid arthritis, particularly targeting those in their fifth or sixth decade who are considered too young for total knee replacement surgery. The company operates within the Health Tech & Life Sciences sector, specifically in Medical Devices and Medical Treatment & Therapeutics, serving healthcare providers.

Company Intelligence Q&A

What is Jointech-Med's primary focus?

Jointech-Med's primary focus is on patients suffering from painful knee arthritis with effusion, particularly those in their fifth or sixth decade who are considered too young for knee replacement surgery.

Who are the founders of Jointech-Med?

Jointech-Med was founded by Natanja Slager and Nir Altschuler.

What is the core technology developed by Jointech-Med?

Jointech-Med is developing an intra-articular device designed to reduce intra-articular pressure and facilitate the continuous evacuation of inflammatory mediators from painful, effused knees.

What problem does Jointech-Med aim to solve?

Jointech-Med aims to decrease pain, improve life quality, and decelerate disease propagation in joints affected by conditions such as osteoarthritis and rheumatoid arthritis by reducing intra-articular pressure and inflammation.

When was Jointech-Med founded?

Jointech-Med was founded in May 2008.